Aging and Alzheimer's disease. Altered cortical serotonergic binding

Area of Science:

• Neuroscience
• Neurochemistry
• Neuropathology

Background:

• Serotonin and dopamine receptors are crucial in brain function.
• Alterations in neurotransmitter systems are implicated in Alzheimer's disease (AD).
• Frontal pole membranes offer a site to study receptor binding changes.

Purpose of the Study:

• To investigate changes in serotonin and spiperone binding in human frontal poles.
• To compare receptor binding in controls, normal aging, and Alzheimer's disease (AD) subjects.
• To determine if binding changes in AD are related to receptor number.

Main Methods:

• Radioligand binding assays using tritiated serotonin and spiperone.
• Crude membrane preparations from human frontal poles.
• Use of sulpiride to confirm spiperone binding specificity.

Main Results:

• Spiperone binding in the cortex is primarily serotonergic.
• Both normal aging and AD showed a decline in serotonin binding.
• Only Alzheimer's disease (AD) exhibited a specific decrease in spiperone binding, independent of age or disease duration.
• Scatchard analysis indicated reduced receptor numbers for both age- and disease-related decrements.

Conclusions:

• Alzheimer's disease (AD) is associated with a specific reduction in spiperone binding sites in the frontal pole.
• Both normal aging and AD impact serotonin receptor binding.
• The observed decrements in binding are attributed to a decrease in the number of available receptors.